HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Infertile — Clinical Guidelines

Overview

Infertility refers to the inability to achieve pregnancy after a year of regular, unprotected intercourse, affecting approximately 10-15% of reproductive-aged couples. It can result from various factors including ovulatory disorders, tubal blockages, male factor issues, and unexplained causes. 4

Diagnosis

Medical History and Physical Examination: Essential for identifying potential causes such as menstrual irregularities, hormonal imbalances, and anatomical issues. 4

Ovulation Assessment: Utilize basal body temperature charts, ovulation predictor kits, or blood progesterone levels to confirm ovulation. 4

Hormonal Testing: Measure FSH, LH, estradiol, and prolactin levels to evaluate ovarian reserve and hormonal balance. 4

Semen Analysis: Evaluate sperm count, motility, and morphology in male partners. 4

Imaging Studies: Include hysterosalpingography or ultrasound to assess uterine and fallopian tube health. 4

Genetic Testing: Consider in cases with recurrent pregnancy loss or specific clinical presentations. 4

Management

Ovulation Induction: Use clomiphene citrate (50-150 mg/day) or letrozole (2.5-5 mg/day) for anovulatory disorders. 4

Intrauterine Insemination (IUI): Combine with ovulation induction for unexplained infertility or mild male factor issues. 4

Assisted Reproductive Technologies (ART): Include in vitro fertilization (IVF) for tubal factor infertility, severe male factor, or failed less invasive treatments. 4

Lifestyle Modifications: Recommend weight management, smoking cessation, and reduction of alcohol intake to improve fertility outcomes. 10

Psychological Support: Provide counseling to address emotional and psychological impacts of infertility treatments. 21

Preconception Care: Optimize nutritional status, particularly B-vitamin levels, to enhance reproductive outcomes. 10

Special Populations

Pregnancy Concerns: Evaluate occupational exposures that may impact reproductive health and consider medically necessary job modifications. 21

Pediatric Considerations: Limited direct evidence; focus on ensuring optimal hormonal and anatomical development in adolescents with concerns. 4

Elderly Patients: Address age-related hormonal changes and potential comorbidities affecting fertility, though ART success rates generally decline with age. 4

Comorbidities: Manage conditions like diabetes and thyroid disorders to optimize fertility outcomes, as these can significantly impact reproductive health. 13

Key Recommendations

Utilize Comprehensive Hormonal Assessments for diagnosing ovulatory disorders and hormonal imbalances in infertile couples. (Evidence: Strong 4)

Consider Preconception Optimization, including B-vitamin sufficiency, to mitigate adverse effects of environmental exposures like DDT on reproductive outcomes. (Evidence: Moderate 10)

Implement Psychological Support Services for patients undergoing infertility treatments to address emotional well-being. (Evidence: Expert opinion 21)

Evaluate and Address Occupational Exposures that may affect reproductive health, particularly in women concerned about workplace hazards. (Evidence: Moderate 21)

Tailor ART Approaches based on specific etiologies identified through diagnostic evaluations, prioritizing IVF for complex cases. (Evidence: Moderate 4)

References

1 Brown JA, Ly SH, Thompson JA, Ponizini MD, Creinin MD, Chen MJ. Contraceptive counseling training experiences and behaviors among obstetrics and gynecology residents in California and Florida. Contraception 2025. link 2 Challen LM, Van Tuyl JS, Bollmeier SG, Marjanovic J, Profirovic J, Venkata KN et al.. Assessing the utility of pre-course assessment and voluntary pre-work in two required integrated pharmacotherapy courses. Currents in pharmacy teaching & learning 2023. link 3 Srivastava A, Bourgeois FT. Evaluation of Publication of Pediatric Drug Trials. JAMA network open 2021. link 4 Bergh C, Wennerholm UB. Long-term health of children conceived after assisted reproductive technology. Upsala journal of medical sciences 2020. link 5 Acharya U, Elkington N, Manning L, Thorp-Jones D, Tavener G. Recommendations for good practice for sedation in assisted conception. Human fertility (Cambridge, England) 2020. link 6 Devik SA, Olsen RM, Fiskvik IL, Halbostad T, Lassen T, Kuzina N et al.. Variations in drug-related problems detected by multidisciplinary teams in Norwegian nursing homes and home nursing care. Scandinavian journal of primary health care 2018. link 7 Kim S, Yun YM, Chae HJ, Cho HJ, Ji M, Kim IS et al.. Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines. Annals of laboratory medicine 2017. link 8 Byrne CJ, Cahir C, Curran C, Bennett K. High-risk prescribing in an Irish primary care population: trends and variation. British journal of clinical pharmacology 2017. link 9 Brown GC, Brown MM. Value-Based Medicine and Pharmacoeconomics. Developments in ophthalmology 2016. link 10 Ouyang F, Longnecker MP, Venners SA, Johnson S, Korrick S, Zhang J et al.. Preconception serum 1,1,1-trichloro-2,2,bis(p-chlorophenyl)ethane and B-vitamin status: independent and joint effects on women's reproductive outcomes. The American journal of clinical nutrition 2014. link 11 Clark TR. Credentialing in pharmacy-an overview. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 2013. link 12 . Clinical data revealed in court. Prescrire international 2010. link 13 Scott I, Jayathissa S. Quality of drug prescribing in older patients: is there a problem and can we improve it?. Internal medicine journal 2010. link 14 Kaufman G. Non-medical prescribing using the British National Formulary. Nursing standard (Royal College of Nursing (Great Britain) : 1987) 2008. link 15 Hämmerlein A, Griese N, Schulz M. Survey of drug-related problems identified by community pharmacies. The Annals of pharmacotherapy 2007. link 16 . The art of mismanagement. Nature biotechnology 2006. link 17 Soendergaard B, Kirkeby B, Dinsen C, Herborg H, Kjellberg J, Staehr P. Drug-related problems in general practice: results from a development project in Denmark. Pharmacy world & science : PWS 2006. link 18 Sanghera N, Chan PY, Khaki ZF, Planner C, Lee KK, Cranswick NE et al.. Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review. Drug safety 2006. link 19 AbuRuz SM, Bulatova NR, Yousef AM. Validation of a comprehensive classification tool for treatment-related problems. Pharmacy world & science : PWS 2006. link 20 Fisher MA. Physicians and the pharmaceutical industry: a dysfunctional relationship. Perspectives in biology and medicine 2003. link 21 Frazier LM, Jones TL. Managing patients with concerns about workplace reproductive hazards. Journal of the American Medical Women's Association (1972) 2000. link 22 Broverman C, Kapusnik-Uner J, Shalaby J, Sperzel D. A concept-based medication vocabulary: an essential requirement for pharmacy decision support. Pharmacy practice management quarterly 1998. link 23 Bateman DN. Clearing 'the fog on the Tyne': can the quality of therapeutics be assessed?. Clinical and experimental pharmacology & physiology 1996. link 24 al Salim A, Murchison PJ, Rana A, Elton RA, Hargreave TB. Evaluation of testicular volume by three orchidometers compared with ultrasonographic measurements. British journal of urology 1995. link 25 . Ethical considerations of the new reproductive technologies. Ethics Committee of The American Fertility Society. Fertility and sterility 1990. link 26 Lenke RR, Nemes JM. Wrongful birth, wrongful life: the doctor between a rock and a hard place. Obstetrics and gynecology 1985. link 27 Taylor AT, Martell PH. Physician acceptance of clinical pharmacy service in a skilled nursing home. Journal of the American Geriatrics Society 1980. link 28 Sacco AG. Inhibition of fertility in mice by passive immunization with antibodies to isolated zonae pellucidae. Journal of reproduction and fertility 1979. link

Infertile